The Use of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Scoping Review
Viktor Kunder, Kiran C Sharma, Zehra Rizvi, Ricardo Soubelet, Monika Ducharme, Viktor Kunder, Kiran C Sharma, Zehra Rizvi, Ricardo Soubelet, Monika Ducharme
Abstract
Platelet-rich plasma (PRP) has been recognized as a method of treatment in medicine since the 1980s. It primarily functions by releasing cytokines and growth factors that promote wound healing; these growth-promoting factors released by PRP enact new processes such as angiogenesis, collagen deposition, and tissue formation that can change wound-healing outcomes. Many studies recognize that PRP aids in chronic wound healing, which is advantageous for patients who suffer from chronic diabetic foot ulcers (DFUs). This scoping review aims to examine the literature to identify the efficacy of PRP use in the healing of DFUs. The objective of this study is to explore whether PRP has a beneficial effect on healing completeness and the rate of healing on DFUs. Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we searched randomized-controlled trials involving PRP use in diabetic patients with foot ulcers using PubMed, Medline, CINAHL Complete, and Cochrane Database of Systematic Reviews. We restricted the search to articles published during 2005-2022, full texts in the English language, articles involving patients aged 19 years or older, articles that used PRP specifically on DFUs, articles that included a control group, and articles with human subjects. The initial search yielded 119 articles after removing duplicates. The final analysis for relevance yielded eight articles. In seven of the eight studies, the PRP group showed significant results, with either faster healing, more complete healing, or a larger percentage of healed participants. In the one study that did not give conclusive evidence of accelerated healing with PRP, PRP was used as an adjunct to fat grafting and only used once. Application styles of PRP for treatment were shown to influence the level of healing in patients, with injected PRP appearing to achieve the best results compared to topical PRP application. However, this was not conclusive due to the involvement of several other variables. Two studies additionally found PRP to be useful in healing refractory DFUs, and one study found that PRP use in patients with additional comorbidities was still more effective in healing DFUs than standard wound control. This study used scoping review methodology with randomized-controlled trials to examine the literature regarding PRP use in the healing of DFUs. The evidence suggests that PRP is a useful tool in reducing healing times and improving rates of complete wound healing in DFUs. There is room for further research in the application styles of PRP before conclusive statements can be made on the efficacy of injected versus topical PRP healing, based on the findings in this study. The results of this review provide a baseline for further research on PRP use in patients with diabetes and can be used by physicians and public health experts to guide future treatment options for DFUs.
Keywords: diabetic foot ulcers; diabetic ulcers; non-healing ulcers; platelet rich plasma; platelet-rich plasma; prp; wound care.
Conflict of interest statement
The authors have declared that no competing interests exist.
Copyright © 2023, Kunder et al.
Figures
References
- Case series of patients with chronic foot ulcers treated with autologous platelet-rich plasma. Yotsu RR, Hagiwara S, Okochi H, Tamaki T. J Dermatol. 2015;42:288–295.
- Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series. Suthar M, Gupta S, Bukhari S, Ponemone V. J Biomed Sci. 2017;24:16.
- Evaluation of the efficacy of platelet-rich plasma on healing of clean diabetic foot ulcers: A randomized clinical trial in Tehran, Iran. Malekpour Alamdari N, Shafiee A, Mirmohseni A, Besharat S. Diabetes Metab Syndr. 2021;15:621–626.
- A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Driver VR, Hanft J, Fylling CP, Beriou JM. Ostomy Wound Manage. 2006;52:68-70, 72, 74 passim.
- Platelet-rich plasma versus platelet-poor plasma in the management of chronic diabetic foot ulcers: a comparative study. Saad Setta H, Elshahat A, Elsherbiny K, Massoud K, Safe I. Int Wound J. 2011;8:307–312.
- Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial. Li L, Chen D, Wang C, et al. Wound Repair Regen. 2015;23:495–505.
- Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ahmed M, Reffat SA, Hassan A, Eskander F. Ann Vasc Surg. 2017;38:206–211.
- Role of platelet-rich plasma in healing diabetic foot ulcers: A prospective study. Singh SP, Kumar V, Pandey A, Pandey P, Gupta V, Verma R. J Wound Care. 2018;27:550–556.
- Randomized controlled trial on autologous platelet-rich plasma versus saline dressing in treatment of non-healing diabetic foot ulcers. Elsaid A, El-Said M, Emile S, Youssef M, Khafagy W, Elshobaky A. World J Surg. 2020;44:1294–1301.
- Fat grafting and platelet-rich plasma for the treatment of diabetic foot ulcers: A feasibility-randomised controlled trial. Smith OJ, Leigh R, Kanapathy M, et al. Int Wound J. 2020;17:1578–1594.
Source: PubMed